CLVT vs. MEDP, HQY, BILI, WPP, LYFT, ETSY, AMTM, MARA, SEZL, and WSC
Should you be buying Clarivate stock or one of its competitors? The main competitors of Clarivate include Medpace (MEDP), HealthEquity (HQY), Bilibili (BILI), WPP (WPP), Lyft (LYFT), Etsy (ETSY), Amentum (AMTM), Marathon Digital (MARA), Sezzle (SEZL), and WillScot (WSC). These companies are all part of the "business services" industry.
Clarivate vs. Its Competitors
Medpace (NASDAQ:MEDP) and Clarivate (NYSE:CLVT) are both mid-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.
Medpace has a net margin of 19.31% compared to Clarivate's net margin of -26.32%. Medpace's return on equity of 54.36% beat Clarivate's return on equity.
Medpace currently has a consensus target price of $344.82, indicating a potential upside of 5.76%. Clarivate has a consensus target price of $5.00, indicating a potential upside of 12.11%. Given Clarivate's higher possible upside, analysts plainly believe Clarivate is more favorable than Medpace.
Medpace has higher earnings, but lower revenue than Clarivate. Clarivate is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.
78.0% of Medpace shares are held by institutional investors. Comparatively, 85.7% of Clarivate shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 23.2% of Clarivate shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Medpace has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Clarivate has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500.
In the previous week, Medpace and Medpace both had 6 articles in the media. Medpace's average media sentiment score of 0.82 beat Clarivate's score of 0.74 indicating that Medpace is being referred to more favorably in the media.
Summary
Medpace beats Clarivate on 10 of the 14 factors compared between the two stocks.
Get Clarivate News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLVT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CLVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Clarivate Competitors List
Related Companies and Tools
This page (NYSE:CLVT) was last updated on 7/2/2025 by MarketBeat.com Staff
Free CLVT Stock Alerts